is pioglitazone a glp 1 with SGLT2 inhibitors or GLP-1 receptor agonists in patients with type 2 diabetes and non-alcoholic fatty liver disease: could the combinations of an old friend with new players yield better outcomes? Overcoming Insulin Resistance in Type

doi: 10.1055/a-0752-0741 17 LopesMBS

[DOI] [PMC free article] [PubMed] [Google Scholar] 201.Basli A., Soulet S., Chaher N., Mrillon J.-M., Chibane M., Monti J.-P., Richard T

Why Symptoms May Persist After Exposure Ends Environmental removal is foundational, but it does not automatically restore immune balance

The common factors among this group include having established strong exercise habits during treatment (particularly resistance training), having completely overhauled eating patterns with a focus on high-protein whole-food diets, gradual tapering rather than abrupt discontinuation, and having lost weight slowly enough for metabolic adaptation to partially recalibrate